The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Carruthers Michael since 2005.
The trader's CIK number is 1184335.
At the time of the last reporting, Carruthers Michael was the CFO of Array Biopharma Inc. (stock ticker symbol ARRY).
Also see all insider trading activities at Array Biopharma Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2013 | ARRY | 0 | $0 | 0 | $0 | 15,321 | $57,453 |
| 2012 | ARRY | 0 | $0 | 3,539 | $8,201 | 0 | $0 |
| 2011 | ARRY | 0 | $0 | 19,387 | $49,064 | 0 | $0 |
| 2010 | ARRY | 0 | $0 | 26,886 | $75,481 | 0 | $0 |
| 2009 | ARRY | 0 | $0 | 11,089 | $30,504 | 0 | $0 |
| 2008 | ARRY | 0 | $0 | 0 | $0 | 42,859 | $18,162 |
| 2007 | ARRY | 0 | $0 | 10,000 | $130,000 | 20,000 | $4,700 |
| 2006 | ARRY | 0 | $0 | 53,779 | $543,902 | 0 | $0 |
| 2005 | ARRY | 0 | $0 | 10,000 | $61,500 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-07-24 | ARRY | Option Ex | 15,321 | 3.75 | 57,453 |
| 2012-02-10 | ARRY | Sale | 1,545 | 2.65 | 4,094 |
| 2012-01-12 | ARRY | Sale | 1,994 | 2.06 | 4,107 |
| 2011-12-12 | ARRY | Sale | 1,743 | 2.35 | 4,096 |
| 2011-11-11 | ARRY | Sale | 1,656 | 2.47 | 4,090 |
| 2011-10-12 | ARRY | Sale | 1,977 | 2.08 | 4,112 |
| 2011-09-12 | ARRY | Sale | 2,034 | 2.02 | 4,108 |
| 2011-08-12 | ARRY | Sale | 1,810 | 2.26 | 4,090 |
| 2011-07-12 | ARRY | Sale | 1,638 | 2.50 | 4,095 |
| 2011-06-10 | ARRY | Sale | 1,720 | 2.38 | 4,093 |
| 2011-05-12 | ARRY | Sale | 1,484 | 2.75 | 4,081 |
| 2011-04-12 | ARRY | Sale | 1,340 | 3.04 | 4,073 |
| 2011-03-11 | ARRY | Sale | 1,310 | 3.11 | 4,074 |
| 2011-02-11 | ARRY | Sale | 1,403 | 2.91 | 4,082 |
| 2011-01-12 | ARRY | Sale | 1,272 | 3.20 | 4,070 |
| 2010-12-10 | ARRY | Sale | 1,256 | 3.24 | 4,069 |
| 2010-11-12 | ARRY | Sale | 1,220 | 3.33 | 4,062 |
| 2010-10-12 | ARRY | Sale | 1,225 | 3.32 | 4,067 |
| 2010-09-14 | ARRY | Sale | 1,415 | 2.88 | 4,075 |
| 2010-08-23 | ARRY | Sale | 17 | 2.79 | 47 |
| 2010-07-23 | ARRY | Sale | 1,309 | 3.11 | 4,070 |
| 2010-06-23 | ARRY | Sale | 1,208 | 3.37 | 4,070 |
| 2010-05-21 | ARRY | Sale | 1,183 | 3.44 | 4,069 |
| 2010-04-23 | ARRY | Sale | 1,074 | 3.78 | 4,059 |
| 2010-03-23 | ARRY | Sale | 1,661 | 2.46 | 4,086 |
| 2010-02-23 | ARRY | Sale | 1,707 | 2.40 | 4,096 |
| 2010-02-05 | ARRY | Sale | 6,286 | 2.44 | 15,337 |
| 2010-01-22 | ARRY | Sale | 1,644 | 2.49 | 4,093 |
| 2010-01-06 | ARRY | Sale | 5,681 | 2.69 | 15,281 |
| 2009-12-23 | ARRY | Sale | 1,533 | 2.66 | 4,077 |
| 2009-11-23 | ARRY | Sale | 2,045 | 2.01 | 4,110 |
| 2009-10-23 | ARRY | Sale | 2,049 | 2.00 | 4,108 |
| 2009-09-25 | ARRY | Sale | 1,315 | 2.77 | 3,642 |
| 2009-08-24 | ARRY | Sale | 882 | 4.17 | 3,677 |
| 2009-07-30 | ARRY | Sale | 925 | 3.95 | 3,653 |
| 2009-06-22 | ARRY | Sale | 1,170 | 3.06 | 3,580 |
| 2009-05-26 | ARRY | Sale | 1,170 | 3.13 | 3,657 |
| 2008-02-26 | ARRY | Option Ex | 22,165 | .60 | 13,299 |
| 2008-01-04 | ARRY | Option Ex | 20,694 | .23 | 4,863 |
| 2007-09-19 | ARRY | Sale | 10,000 | 13.00 | 130,000 |
| 2007-02-15 | ARRY | Option Ex | 20,000 | .23 | 4,700 |
| 2006-11-10 | ARRY | Sale | 11,816 | 11.98 | 141,555 |
| 2006-11-13 | ARRY | Sale | 3,054 | 11.98 | 36,586 |
| 2006-11-08 | ARRY | Sale | 10,000 | 10.85 | 108,500 |
| 2006-10-27 | ARRY | Sale | 5,000 | 9.95 | 49,750 |
| 2006-03-07 | ARRY | Sale | 5,000 | 9.49 | 47,450 |
| 2006-02-17 | ARRY | Sale | 5,000 | 8.99 | 44,950 |
| 2006-02-15 | ARRY | Sale | 5,000 | 8.49 | 42,450 |
| 2006-02-10 | ARRY | Sale | 4,506 | 8.16 | 36,768 |
| 2006-02-13 | ARRY | Sale | 4,403 | 8.15 | 35,893 |
| 2005-06-21 | ARRY | Sale | 5,000 | 6.15 | 30,750 |
| 2005-06-21 | ARRY | Sale | 5,000 | 6.15 | 30,750 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Carruthers Michael (CFO of Array Biopharma Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.